True Leaf Adds Dr. Conny Mosley to Veterinary Advisory Board
Dr. Conny Mosley has joined True Leaf’s Veterinary Advisory Board.
True Leaf Medicine International Ltd., a cannabis and hemp wellness brand for pets, has added Conny Mosley, Dr. Med. Vet., Dipl. (ACVAA), CVA, to the True Leaf Veterinary Advisory Board.
Dr. Mosley joins Katherine Kramer, DVM, Dipl. ABVP (canine/feline), CVA, CVTP, who is the founding chair of the board.
“We are proud to welcome another top veterinarian dedicated to advancing cannabis-based therapies for pets to the True Leaf Veterinary Advisory Board,” said Darcy Bomford, founder and CEO of True Leaf in Vernon, British Columbia, Canada. “Our commitment to be the leading global cannabis-for-pets brand starts with product excellence. We are working side-by-side with our veterinary advisors to research and develop the safest, most effective cannabis products for pets. Dr. Mosley will be a key member of our team as we work toward launching a best-to-market cannabidiol (CBD) product for pets and begin development on a veterinary exclusive line.”
Mosley is a director and vice-president of the Canadian Association of Veterinary Cannabinoid Medicine (CAVCM) and brings more than 20 years of experience in veterinary medicine to True Leaf. She currently leads the integrative pain management service at the VCA Canada 404 Veterinary Emergency and Referral Hospital in Newmarket, Ontario.
Mosley is a strong advocate for cannabis-based therapies for animals, and through her work at CAVCM, and with the Canadian Veterinary Medical Association, is encouraging Health Canada to amend the Access to Cannabis for Medical Purposes Regulations to permit the future classification of CBD as a Veterinary Health Product. This would open the door for True Leaf to bring legal and quality-controlled CBD products for pets to market in Canada, according to company officials.
“Veterinary clinics across the country are seeing strong client demand for legal and effective medicinal cannabis products for pets,” Mosley said. “I joined True Leaf because its team of pet industry veterans are at the forefront of evidence-based product development.
“In this new role, I look forward to continuing research on cannabinoid medicine to target specific pet health challenges, educating the veterinary community and pet parents on the benefits of cannabis for pets, and helping guide the development of cannabis products that veterinarians can trust.”